CATALYST DOSSIER · UPDATED 2026-10-20
$PFHO
Unclassified · convergence — · conviction —
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $PFHO?
Quantitative
Revenue (CY2026Q1) : $1.5M (-17.6% YoY)
Net Income (CY2026Q1) : $193.7K (-33.8% YoY)
Catalysts
Multi-spoke convergence : 5 convergent signals fired: auto_macro_edgar_fts, auto_macro_nasa_power, auto_macro_ofr_fsi, auto_macro_options_gex, auto_macro_vix_term
Risks
Position-sizing discipline : Conviction AVOID (-22 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Multiple compression : If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis
Sympathy basket (cerebro)
BSP via tech r=+0.86 sympathetic (score 13)
QTWO via tech r=+0.86 sympathetic (score 13)
WTTR via materials r=+0.83 sympathetic (score 14)
INHD via materials r=+0.83 sympathetic (score 13)
SKHY via semis r=+0.77 sympathetic (score 5)
MVIS via semis r=+0.77 sympathetic (score 3)
Signals Firing
No active signals this cycle.
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.